3/5
08:07 pm
cmpx
Compass Therapeutics (CMPX) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Neutral
Report
Compass Therapeutics (CMPX) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
3/5
01:08 pm
cmpx
Compass Therapeutics (CMPX) had its "outperform" rating reaffirmed by William Blair.
Low
Report
Compass Therapeutics (CMPX) had its "outperform" rating reaffirmed by William Blair.
3/5
01:08 pm
cmpx
Compass Therapeutics (CMPX) had its "outperform" rating reaffirmed by Raymond James Financial, Inc..
Low
Report
Compass Therapeutics (CMPX) had its "outperform" rating reaffirmed by Raymond James Financial, Inc..
3/5
08:08 am
cmpx
Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
3/5
07:30 am
cmpx
Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update
Low
Report
Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update
3/3
04:28 am
cmpx
Assessing Compass Therapeutics (CMPX) Valuation As CTX-009 Gains Attention In Biliary Tract Cancer Market [Yahoo! Finance]
Medium
Report
Assessing Compass Therapeutics (CMPX) Valuation As CTX-009 Gains Attention In Biliary Tract Cancer Market [Yahoo! Finance]
3/2
05:46 pm
cmpx
Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight [Yahoo! Finance]
Medium
Report
Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight [Yahoo! Finance]
3/2
05:31 pm
cmpx
Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight
Low
Report
Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight
3/2
05:31 pm
cmpx
Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight
Low
Report
Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight
3/2
12:53 pm
cmpx
Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing [Yahoo! Finance]
Low
Report
Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing [Yahoo! Finance]
2/17
11:41 am
cmpx
Is Compass Therapeutics, Inc. (CMPX) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]
Low
Report
Is Compass Therapeutics, Inc. (CMPX) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]
2/16
01:08 am
cmpx
Compass Therapeutics (NASDAQ:CMPX) was upgraded by analysts at
Wall Stre
Low
Report
Compass Therapeutics (NASDAQ:CMPX) was upgraded by analysts at
Wall Stre
2/13
09:00 am
cmpx
Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $15.00 price target on the stock.
Medium
Report
Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $15.00 price target on the stock.
2/8
02:05 am
cmpx
Compass Therapeutics (NASDAQ:CMPX) was downgraded by analysts at
Wall St
Low
Report
Compass Therapeutics (NASDAQ:CMPX) was downgraded by analysts at
Wall St
2/4
08:42 am
cmpx
Compass Therapeutics (NASDAQ:CMPX) was given a new $13.00 price target on by analysts at Canaccord Genuity Group Inc..
Medium
Report
Compass Therapeutics (NASDAQ:CMPX) was given a new $13.00 price target on by analysts at Canaccord Genuity Group Inc..
1/31
01:33 am
cmpx
Compass Therapeutics (NASDAQ:CMPX) was upgraded by analysts at
Wall Stre
Low
Report
Compass Therapeutics (NASDAQ:CMPX) was upgraded by analysts at
Wall Stre
1/20
11:26 am
cmpx
Compass Therapeutics: Exciting Clinical Updates Inbound For 2026 [Seeking Alpha]
Neutral
Report
Compass Therapeutics: Exciting Clinical Updates Inbound For 2026 [Seeking Alpha]
1/19
05:06 pm
cmpx
Compass Therapeutics, Inc. (CMPX): A Bull Case Theory [Yahoo! Finance]
Low
Report
Compass Therapeutics, Inc. (CMPX): A Bull Case Theory [Yahoo! Finance]
1/17
01:11 am
cmpx
Compass Therapeutics (NASDAQ:CMPX) was downgraded by analysts at
Wall St
Low
Report
Compass Therapeutics (NASDAQ:CMPX) was downgraded by analysts at
Wall St
1/16
09:38 pm
cmpx
Assessing Compass Therapeutics (CMPX) Valuation After Strong 1 Year Share Price Performance [Yahoo! Finance]
Low
Report
Assessing Compass Therapeutics (CMPX) Valuation After Strong 1 Year Share Price Performance [Yahoo! Finance]
1/16
03:41 am
cmpx
Is Compass Therapeutics (CMPX) Quietly Rewriting Its Oncology Strategy With New Commercial and Medical Chiefs? [Yahoo! Finance]
Low
Report
Is Compass Therapeutics (CMPX) Quietly Rewriting Its Oncology Strategy With New Commercial and Medical Chiefs? [Yahoo! Finance]
1/6
07:03 pm
cmpx
Compass Therapeutics Provides Corporate Update [Yahoo! Finance]
High
Report
Compass Therapeutics Provides Corporate Update [Yahoo! Finance]
1/6
02:14 pm
cmpx
Compass Therapeutics (NASDAQ:CMPX) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Low
Report
Compass Therapeutics (NASDAQ:CMPX) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
1/6
09:55 am
cmpx
Compass Therapeutics (NASDAQ:CMPX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $30.00 price target on the stock.
Neutral
Report
Compass Therapeutics (NASDAQ:CMPX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $30.00 price target on the stock.
1/6
08:00 am
cmpx
Compass Therapeutics Provides Corporate Update
Medium
Report
Compass Therapeutics Provides Corporate Update